X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

FOLIA NEUROPATHOLOGICA

期刊標題檢索 FOLIA NEUROPATH 最新評論: Post hoc comparison refers to setting additional groups based on the c... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[FOLIA NEUROPATHOLOGICA]您好,您是該頁面的第 17224 位訪客。

期刊簡介
期刊名稱FOLIA NEUROPATHOLOGICA FOLIA NEUROPATHOLOGICA
LetPub Score
4.8
50 ratings
Rate

Reputation
5.7

Influence
3.6

Speed
7.0

期刊簡稱FOLIA NEUROPATHOL
ISSN1641-4640
E-ISSN1509-572X
h-index31
CiteScore
CiteScoreSJRSNIPCiteScore Rank
2.500.4000.381
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pathology and Forensic Medicine
Q3111 / 208
Category: Medicine
Subcategory: Neurology (clinical)
Q3253 / 400

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Folia Neuropathologica is an official journal of the Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. The journal publishes original articles and reviews that deal with all aspects of clinical and experimental neuropathology and related fields of neuroscience research. The scope of journal includes surgical and experimental pathomorphology, ultrastructure, immunohistochemistry, biochemistry and molecular biology of the nervous tissue. Papers on surgical neuropathology and neuroimaging are also welcome. The reports in other fields relevant to the understanding of human neuropathology might be considered.
官方網站http://www.termedia.pl/Journal/-20
在線稿件提交http://www.editorialsystem.com/fn
開放訪問Yes
出版商Termedia Publishing House Ltd.
主題領域医学
出版國/地區POLAND
發行頻率四半期刊行
創刊年1994
每年文章數49每年文章數趨勢
黃金OA百分比98.57%
OA Related Info
APC: Yes( EUR250; )
APC waiver:No
Other charges: Check Notes
Keywords: clinical and experimental neuropathology、neuroscience research
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q3

CategoryEditionJIF QuartileJIF RankingJIF Percentage
NEUROSCIENCESSCIEQ4269/310
PATHOLOGYSCIEQ356/88
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1641-4640%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: >12 Week(s), or Invited contributions
競爭力 *來自作者的數據: Moderate
參考鏈接
相關期刊 【FOLIA NEUROPATHOLOGICA】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Annual Review of Pathology-Mechanisms of DiseaseH-index: 105

    CiteScore: 62.60
    ENDOCRINE PATHOLOGYH-index: 42

    CiteScore: 12.30
    ACTA NEUROPATHOLOGICAH-index: 146

    CiteScore: 23.70
    Seminars in ImmunopathologyH-index: 85

    CiteScore: 19.80
    MODERN PATHOLOGYH-index: 139

    CiteScore: 14.30
    BRAIN PATHOLOGYH-index: 124

    CiteScore: 13.20
    JOURNAL OF PATHOLOGYH-index: 168

    CiteScore: 14.10
    ADVANCES IN ANATOMIC PATHOLOGYH-index: 69

    CiteScore: 10.30
    LABORATORY INVESTIGATIONH-index: 140

    CiteScore: 8.30
    AMERICAN JOURNAL OF PATHOLOGYH-index: 258

    CiteScore: 11.40
    學科內最受檢索的期刊 頁面查看次數
    Molecular Medicine Reports314297
    DISEASE MARKERS92609
    PATHOLOGY RESEARCH AND PRACTICE68295
    LABORATORY INVESTIGATION67483
    JOURNAL OF PATHOLOGY65723
    AMERICAN JOURNAL OF PATHOLOGY61174
    ACTA NEUROPATHOLOGICA44158
    Diagnostic Pathology43859
    PATHOLOGY & ONCOLOGY RESEARCH43748
    MODERN PATHOLOGY41699
  •  

    FOLIA NEUROPATHOLOGICA FOLIA NEUROPATHOLOGICA
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [FOLIA NEUROPATHOLOGICA] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 18:44:10 評論於
Post hoc comparison refers to setting additional groups based on the characteristics of the data after data collection is completed, proposing research hypotheses, and conducting statistical analysis; it is to test non-research hypotheses and further exploratory analysis of the results
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 16:18:11 評論於
Comparing afterwards is testing non-research hypotheses. This is very common in actual research: I have completed the experiment, confirmed the hypothesis, but still need to extend the research, so I need to continue exploring the data to see which direction will lead to valuable conclusions. At this point, it is equivalent to testing all possible comparisons (although I cannot actually exhaust all comparisons, all comparisons are potential possibilities due to no specific purpose). Because comparison does not just refer to the difference in means of two treatments, linear combinations of multiple treatments are also comparisons
(0) 讚! | 维尔娜菲茨杰拉德

作者: Oswald Edie


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-28 15:19:59 評論於
Why conduct post-inspection?
(0) 讚! | Oswald Edie

作者: 龙鳞孝礼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 22:05:40 評論於
What is post-hoc testing?
(0) 讚! | 龙鳞孝礼

作者: 降龙霞影


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-28 19:21:41 評論於
How to recommend reviewers span class "quote" mlainian 20140807 publication br Research direction: neuropathological diagnosis Acceptance rate: about 50% Review time: about 2 months The journal is very friendly. I have published a paper in 2014 and felt that it is relatively friendly to Chinese people, but the publication process is too slow. It generally takes a year and a half from submission to publication
(0) 讚! | 降龙霞影

作者: 邻家运馨


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-11-29 19:13:27 評論於
How long does it take to be accepted for submission? Accepted online?
(0) 讚! | 邻家运馨

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 20:02:53 評論於
So-so, as long as I can graduate, it's all good. My senior brother published a paper last year, which also counts as a successful graduation. Everything will be fine
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 18:12:42 評論於
So-so, as long as you can graduate, everything will be fine. My senior brother published a paper last year, which can be considered as a successful graduation, so everything will be all right
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-08-07 18:12:11 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: The journal is very friendly. I had an article published there in 2014 and felt that they were quite friendly towards Chinese authors. However, the publishing process is very slow, taking about a year and a half from submission to publication
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [FOLIA NEUROPATHOLOGICA] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*